ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 5053 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 5053; 2) Community: the network communities that were significantly associated with the response to NSC 5053; 3) Molecule: the relationships between components within communities and NSC 5053; 4) MDR: the compounds that were significantly associated with the NSC 5053.

NSC Compound Enrichment Correlation
NSC 648365 Insulin-Methotrexate conjugate 0.012374497233828 0.03662943
NSC 652175 2-Pyrazolin-5-one, 1-[(2-hydroxyphenyl)carbonyl]- 3-methyl-4-[(4-nitrophenyl)methylene]- 0.012374497233828 -0.14226982
NSC 658370 Null 0.012374497233828 0.20575351
NSC 682831 Butanimidoyl chloride, N-[[[(3-fluorophenyl)amino] carbonyl]oxy]- 0.012374497233828 0.22044541
NSC 683692 .alpha.-D-Glucopyranoside, phenylmethyl 2-acetylamino-2-deoxy- 3-O-[[2-[[2-[1-(aminocarbonyl)-4-[[5-[(1-nitro- 9-acridinyl)amino]pentyl]amino]-4-oxobutyl]amino]- 1-methyl-2-oxoethyl]amino]-1-methyl-2 0.012374497233828 0.11573375
NSC 745343 1-Benzyl-3-hexadecyl-2-methylimidazolium chloride 0.012374497233828 0.5952503
NSC 761769 Null 0.012374497233828 0.54918943
NSC 78629 Naphtho[1,2-b]quinoizinium, 10,13-dimethyl-, chloride 0.012374497233828 0.38916076
NSC 92618 Dichlorodipropyltin 0.012374497233828 0.18267324
NSC 93135 OXYACANTHINE 0.012374497233828 0.28898392
Total:54  Current:11    [First] [Prev] [Next] [Last]